NEW YORK (GenomeWeb News) – Illumina today announced that Science for Life Laboratory has joined the Illumina Genome Network.
SciLifeLab, headquartered in Sweden, is the first IGN partner in Europe and the thirteenth partner in the Illumina program. It will begin a national large-scale population sequencing program aimed at identifying genetic causes of human diseases, Illumina said.
"We now have the opportunity to offer an even larger capacity of high-throughput sequencing to researchers from all over Sweden," Joakim Lundeberg, professor of gene technology at KTH Royal Institute of Technology and director of the National Genomics Infrastructure at SciLifeLab, said in a statement. "In the research program we are about to launch, we aim to sequence more than 1,000 human genomes using the Illumina systems."
IGN connects researchers who need large-scale, whole-genome sequencing with institutions providing the service. Each IGN partner has completed Illumina's certified service provider certification and possesses at least 10 of the company's high-throughput sequencing platforms.
IGN partners include the Broad Institute, McGill University, Cold Spring Harbor Laboratory, the New York Genome Center, and Peking University, among others.